dazed at the scene and required assistance with ambulation immediately after the injury. The patient complained of complete right upper lid ptosis. He did not complain of weakness or uncoordination.
Examination revealed corrected visual acuities of 20/20 OU. He had ecchymosis of the medial right lower lid without skin laceration. There was complete right upper lid ptosis. He had limitation of supraduction, adduction, and abduction of the right eye. His left eye moved normally. The right pupil was fixed and dilated and there was no relative afferent pupillary defect. A subconjunctival hemorrhage was found on the inferior right globe without obvious laceration. There was a slight left hemiparesis with mild dysmetria of the left side.
While a computed tomographic scan revealed no fractures or abnormalities of the retrobulbar structures, a magnetic resonance image showed a hemorrhagic lesion of the right upper pons that extended to the cerebellar vermis (Figure 3) . Cerebral angiography did not show any abnormalities.
A follow-up examination 2 months later revealed no residual hemiparesis and significantly less ptosis and diplopia.
Comment. Previous investigators have found that intracranial penetrating injuries commonly occur via orbital roof fractures, the superior orbital fissure, or the optic foramen.
1,2 None of our patients had obvious orbital fractures on computed tomographic scanning. Also, none of our patients suffered a visual field defect or relative afferent pupillary defect, which made entry through the optic foramen unlikely. The trajectory through the orbital apex, via the superior orbital fissure, points straight to the upper brainstem. A thin object entering in this direction would pass over the top of the clivus as it reaches the posterior fossa. The exact location of the entry wound is important in pathogenesis because lesions through the upper eyelid or above the globe angled through the posterior orbit would strike a location more inferior in the brainstem, which occurred in our second case.
None of our patients suffered serious globe injury. Furthermore, it is remarkable that none of our patients suffered a vascular injury to the internal carotid, basilar, or posterior cerebral arteries and that none of them suffered from delayed meningitis.
Although not unheard of, penetrating injury to the brainstem through the orbit is a rare occurrence and is often fatal. [2] [3] [4] We recommend obtaining magnetic resonance imaging of the brain and intracranial vasculuture in patients who develop diplopia, even after a minor injury to the region around the orbit. The lack of a significant entrance wound in the eyelid or conjunctiva should not dissuade imaging because external injuries may be very subtle, as was the case with our third subject. 3, 5 Patients should be observed closely for the appearance of subsequent meningitis. If patients survive the initial injury, then their prognosis is good for a nearcomplete recovery. 
Pharmacologic Treatment of Congenital Nystagmus
Pharmacologic treatment has been used in acquired nystagmus with mixed success. Treatments have included baclofen, sodium valproate, gabapentin, and memantine. 1, 2 However, in congenital nystagmus, little is known about the effect of drugs. We describe a patient with congenital nystagmus and corneal dystrophy who improved dramatically with gabapentin treatment.
Report of a Case.
A 37-year-old man complained of difficulty crossing roads and reading since childhood due to his poor vision. The patient claimed that these symptoms were alleviated by the consumption of alcohol. He had no oscillopsia. He had congenital nystagmus from birth and was noted at the time to have bilateral corneal opacities. The left eye was amblyopic despite occlusion therapy, and a corneal graft had been performed 20 years previously. Histologic findings from the graft confirmed the diagnosis of congenital granular stromal corneal dystrophy.
The initial visual acuity was 20/80 OD, 20/600 OS, and 20/80 OU. He had a small esotropia in the left eye and a conjugate, horizontal, pendular, and jerk nystagmus. The null point was in pri- After informed consent was obtained, he began taking 600 mg of oral gabapentin in incremental doses of 300 mg at weekly intervals until a total daily dose of 1200 mg was achieved. After 6 weeks of taking 1200 mg/d of gabapentin, he had not noticed a subjective improvement in his vision. The dose of gabapentin was increased to 2400 mg/d in divided doses. After 4 weeks of taking 2400 mg/d of gabapentin, he noticed an improvement in vision and was much more comfortable with close work. Visual acuity was 20/60 OD and 20/60 OU with no change in the left eye.
He remained at the same dose of gabapentin and his vision improved further, to 20/40 −3 OU after 8 weeks of treatment. He has maintained his visual acuity at that level with treatment for a follow-up period of 12 months. He noticed his symptoms worsening when he forgot to take the gabapentin while on vacation. He now feels much more confident crossing roads and believes that the amount of nystagmus in all directions of gaze has been reduced while receiving treatment. He did not notice any adverse effect of gabapentin.
Eye movement recorded with an infrared video pupil tracker (EyeLink eye tracker; SensoMotoric Instruments, Berlin, Germany) confirmed a reduction in the amplitude of his nystagmus compared with pretreatment ( Figure) . Foveation time per second was estimated using the same criteria throughout (±2°/s position window and ±4°/s velocity window), and best-corrected visual acuity was predicted using the expanded nystagmus acuity function (NAF[X]) (www.omlab.org). 3 The nystagmus was most pronounced on left gaze (eg, at 20°e ccentricity). The peak-to-peak amplitudes and frequencies were measured as follows: 6.0°and 5.5 Hz before treatment and 1.5°and 6.0 Hz after treatment. In right gaze (20°ec-centricity), the nystagmus was 3.5°a nd 3.0 Hz before treatment and 1.0°a nd 3.0 Hz after treatment. In primary position, the nystagmus was 2.0°and 3.0 Hz before treatment and 1.0°and 3.5 Hz after treatment. The foveation time per second increased from 0.12 second to 0.92 second in primary position, 0.008 second to 0.60 second in right gaze, and 0.027 second to 0.27 second in left gaze. Using the NAF(X) to predict best-corrected visual acuity, this corresponded to improvements from less than or equal to 20/50 − to less than or equal to 20/25 − in primary position, less than or equal to 20/ 240 − to less than or equal to 20/25 − in right gaze, and less than or equal to 20/180 − to less than or equal to 20/85 ϩ in left gaze. In the right (dominant) eye, the best-corrected visual acuity after gabapentin treatment was 20/40 −3 , whereas the predicted NAF(X) was 20/25 − . The difference could be due to the corneal dystrophy or amblyopia acquired from early childhood nystagmus.
Comment. Gabapentin has been used in the treatment of acquired nystagmus in multiple sclerosis. 4 It is thought to have several possible mechanisms of action, of which the most likely to be involved in nystagmus is its antiglutamatergic activity. Our study shows that gabapentin can reduce nystagmus in congenital nystagmus forms. This suggests that abnormalities in the glutamate and/or ␥-aminobutyric acid system are involved in congenital nystagmus as well. Doublemasked trials are needed to establish the effect of pharmacologic treatment on the various forms of congenital nystagmus.
Correspondence: Dr Sarvananthan, Department of Ophthalmology, Faculty of Medicine and Biological Sciences, Robert Kilpatrick Congenital fibrosis of the extraocular muscles (CFEOM) is a congenital ocular motility disorder that manifests as restrictive ophthalmoplegia with ptosis. 1 Synergistic divergence (SD) is a deficit of adduction associated with simultaneous bilateral abduction on attempted gaze into the field of action of the affected medial rectus muscle. 2 There has been no pathologic report of SD; however, magnetic resonance imaging showed that in 2 patients with CFEOM and SD, the oculomotor nerve was hypoplastic bilaterally and the abducens nerve was absent on the side exhibiting SD. 3 To our knowledge, bilateral deficit of abduction associated with simultaneous bilateral adduction on attempted gaze into the field of action of the lateral rectus muscles, the counterpart of SD, has not been previously reported.
A 39-year-old man was referred for the evaluation of ophthalmoplegia and ptosis since birth. He underwent a bilateral frontalis sling operation at age 29 years. Otherwise, medical and family histories were noncontributory. 
